A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies
A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies
Active, not recruiting · NCT04227847 · Registry updated 2026-09-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, bone marrow disorder, hematologic disorder, leukemia, myelodysplastic syndrome, myeloid leukemia, neoplasm | Active, not recruiting | Phase 1 | 2026-09-09 | NCT04227847 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Seagen, a wholly owned subsidiary of Pfizer | 16 |
52 results · Page 1 of 3
Research sites
Swipe the table sideways for more columns.